CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Truven Health Analytics Meaningful Use Quality Manager 2.0 Gets Federal IT Certification

View Comments
Truven Health
mattroush Matt Roush
Matt Roush joined WWJ Newsradio 950 in September 2001 to spearhead the...
Read More

ANN ARBOR (WWJ) – Truven Health Analytics announced today that its Meaningful Use Quality Manager version 2.0 is now compliant with the 2014 Office of the National Coordinator’s criteria for clinical quality measures reporting.

As of Sept. 18, the product is certified as an Electronic Health Record Module by the Certification Commission for Health Information Technology, an Office of the National Coordinator Authorized Certification Body.

In accordance with the applicable hospital certification criteria adopted by the Secretary of Health and Human Services, the 2014 ONC criteria supports stages 1 and 2 of meaningful use measures required to qualify eligible hospitals for funding under the American Recovery and Reinvestment Act, better known as the federal stimulus.

Truven CEO Mike Boswood said the action is “validating Truven Health Analytics as a leader in clinical quality reporting. And for our customers, it is evidence of our determination to be a valued partner as they navigate evolving reporting standards that could affect hospital funding.”

The 2014 edition certified Meaningful Use Quality Manager 2.0 will accept patient data from any electronic health record system, calculate measures, and generate results. Truven Health will submit the measure results to the Centers for Medicare & Medicaid Services in the standardized electronic formats on behalf of the hospitals, allowing them to meet their Meaningful Use CQM reporting requirement.

The ONC HIT Certification Program certifies that complete EHRs meet all of the 2014 Edition criteria, and EHR modules meet one or more – but not all – of the criteria approved by the Secretary of Health and Human Services (HHS) for either eligible provider or hospital technology.

“CCHIT congratulates companies successfully achieving EHR technology certification,” said Alisa Ray, executive director, CCHIT. “These companies are now able to make their products available to providers wishing to adopt health IT to demonstrate meaningful use and earn federal incentives.”

The Meaningful Use Quality Manager 2.0 certification number is CC-2014-352290-1. ONC HIT Certification conferred by CCHIT does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services.

Meaningful Use Quality Manager 2.0 meets the following certification criteria: § 170.314(c)(1) Clinical Quality Measures – Capture and Export, § 170.314(c)(2) Clinical Quality Measures – Incorporate and Calculate, § 170.314(c)(3) Clinical Quality Measures – Electronic Submission, § 170.314(d)(1) Authentication, Access Control, and Authorization, § 170.314(d)(5) Automatic Log-Off, § 170.314(d)(8) Integrity, and § 170.314(g)(4) Quality Management System.

The clinical quality measures for which Meaningful Use Quality Manager 2.0 has been certified include CMS9v2, Exclusive Breast Milk Feeding; CMS30v3, AMI-10 Statin Prescribed at Discharge; CMS32v3, Median Time from ED Arrival to ED Departure for Discharged ED Patients; CMS53v2, AMI patients whose time from hospital arrival to primary PCI is 90 minutes or less; CMS55v2, ED throughput: arrival to admission time; CMS60v2, AMI patients whose time from hospital arrival to fibrinolysis is 30 minutes or less; CMS71v3, Ischemic stroke: anticoagulation for A-fib/flutter; CMS72v2, Ischemic or hemorrhagic stroke: Antithrombotic by day 2; CMS73v2, Anticoagulation overlap therapy; CMS91v3, Ischemic stroke: Thrombolytic therapy; CMS100v2, AMI-2-Aspirin Prescribed at Discharge for AMI; CMS102v2, Ischemic or hemorrhagic stroke: rehabilitation assessment; CMS104v2, Ischemic stroke: discharge on anti-thrombotics; CMS105v2, Ischemic stroke: discharge on statins; CMS107v2, Ischemic or hemorrhagic stroke: stroke education; CMS108v2, Venous Thromboembolism (VTE)-1 VTE prophylaxis; CMS109v2, Platelet monitoring on unfractionated heparin; CMS110v2, VTE discharge instructions; CMS111v2, ED throughput: decision to admission time; CMS113v2, PC-01 Elective Delivery Prior to 39 Completed Weeks Gestation; CMS114v2, Incidence of potentially preventable VTE; and CMS190v2, VTE-2 Intensive Care Unit (ICU) VTE prophylaxis.

The additional types of costs that a hospital would pay to implement the Meaningful Use Quality Manager v. 2.0 in order to attempt to meet meaningful use objectives and measures include an annual license fee per hospital and a onetime implementation fee for implementing the 2014 Edition certified product.

More at http://www.truvenhealth.com.

View Comments
blog comments powered by Disqus